APP (sabirnetug) Recombinant Monoclonal Antibody, Clone: [15A10], Unconjugated

Produktübersicht

• Artikelname: APP (sabirnetug) Recombinant Monoclonal Antibody, Clone: [15A10], Unconjugated
• Artikelnummer: CSB-RA001950MA3HU
• Hersteller Artikelnummer: CSB-RA001950MA3HU
• Alternativnummer: CSB-RA001950MA3HU-100UL, CSB-RA001950MA3HU-50UL
• Hersteller: Cusabio
• Kategorie: Antikörper
• Applikation: ELISA, FC, IF
• Spezies Reaktivität: Human
• Konjugation: Unconjugated
• Alternative Synonym: A4 antibody, A4_HUMAN antibody, AAA antibody, ABETA antibody, ABPP antibody, AICD-50 antibody, AICD-57 antibody, AICD-59 antibody, AID(50) antibody, AID(57) antibody, AID(59) antibody, Alzheimer disease amyloid protein antibody, Amyloid intracellular domain 50 antibody, Amyloid intracellular domain 57 antibody, Amyloid intracellular domain 59 antibody, APP antibody, APPI antibody, Beta amyloid protein 42 antibody, Beta APP42 antibody, Beta-APP40 antibody, Beta-APP42 antibody, C31 antibody, Cerebral vascular amyloid peptide antibody, CVAP antibody, Gamma-CTF(50) antibody, Gamma-CTF(57) antibody, Gamma-CTF(59) antibody, PN-II antibody, PreA4 antibody, Protease nexin-II antibody, S-APP-alpha antibody, S-APP-beta antibody, sabirnetug

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [15A10]
• UniProt: P05067
• Puffer: Preservative: 0.03% Proclin 300<br />Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
• Reinheit: Affinity-chromatography
• Formulierung: Liquid
• Target-Kategorie: APP
• Antibody Type: Recombinant Antibody

Anwendungsbeschreibung

• Application Verdünnung: Recommended dilution: IF:1:50-1:200, FC:1:50-1:200

Bilder

Overlay Peak curve showing hela cells stained with CSB-RA001950MA3HU (red line) at 1:100. The cells were fixed in 4% formaldehyde and permeated by 0.2% TritonX-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*106cells) for 45min at 4°C. The secondary antibody used was FITC-conjugated Goat Anti-human IgG(H+L) at 1:200 dilution for 35min at 4°C.Control antibody (green line) was human IgG (1ug/1*106cells) used under the same conditions. Acquisition of >10,000 events was performed.

ImmunofluorescencestainingofHelacellwithCSB-RA001950MA3HUat1:30,counter-stainedwithDAPI.Thecellswerefixedin4%formaldehydeandblockedin10%normalGoatSerum.Thecellswerethenincubatedwiththeantibodyovernightat4C.ThesecondaryantibodywasFITC-conjugatedAffiniPureGoatAnti-HumanIgG(H+L) .

ImmunofluorescencestainingofA549cellwithCSB-RA001950MA3HUat1:30,counter-stainedwithDAPI.Thecellswerefixedin4%formaldehydeandblockedin10%normalGoatSerum.Thecellswerethenincubatedwiththeantibodyovernightat4C.ThesecondaryantibodywasFITC-conjugatedAffiniPureGoatAnti-HumanIgG(H+L) .